This post is from a low-reputation account and contains an unverified outbound link. Be cautious before clicking external links.
HER2-Targeted Therapies: Pioneering the Battle against HER2-Positive Breast Cancer
Words
50
Reading
1 min
Listen
Play
3y
A different subtype of breast cancer known as HER2-positive is aggressive and overexpressed in the human epidermal growth factor receptor 2 (HER2) gene. The landscape of treatment for this population of breast cancer patients has been transformed throughout time by ground-breaking research that resulted in the creation of HER2-targeted medicines.